Opendata, web and dolomites


Mechanism of allosteric regulation of SHP2 phosphatase and its role in cancer and geneticdiseases: a multidisciplinary computational, structural and biological approach

Total Cost €


EC-Contrib. €






 MARS project word cloud

Explore the words cloud of the MARS project. It provides you a very rough idea of what is the project "MARS" about.

binding    dysregulation    juvenile    events    atomic    function    deeper    gene    signaling    architecture    consolidated    specialist    hi    complemented    domains    researcher    md    terminal    syndrome    leukemia    regulatory    malignancies    site    containing    xs    transition    tumors    mechanisms    homology    combined    inhibitors    perturb    computational    combination    structure    treat    myelomonocytic    found    30    dissect    functional    multidomain    dynamics    favoring    ras    inactive    ligand    diseases    regulation    whereas    ray    allosteric    protein    scattering    biology    causes    coupled    individuals    molecules    ptpn11    somatic    italian    activation    peptidomimetic    biochemical    phosphatase    dynamic    disease    encoding    blocks    compounds    external    of    mechanism    src    rarely    compatible    50    noonan    goals    phosphopeptide    guaranteed    hematologic    er    jmml    active    pp    ptp    class    inhibit    mapk    tyrosine    molecular    sh2    implicated    host    shp2    shows    domain    human    expertise    expert    germline    basal    dissociation    assays    mutations   

Project "MARS" data sheet

The following table provides information about the project.


Organization address
postcode: 37073

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 159˙460 €
 EC max contribution 159˙460 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2015
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2017
 Duration (year-month-day) from 2017-04-01   to  2019-03-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 


 Project objective

SHP2 is an SH2 domain-containing protein tyrosine phosphatase with a key role in the RAS-MAPK signaling pathway. Germline mutations in PTPN11, the gene encoding SHP2, occur in 50% of individuals affected by Noonan syndrome, whereas somatic mutations in this gene cause more than 30% of cases of juvenile myelomonocytic leukemia (JMML), and are more rarely found in other hematologic malignancies and tumors. The X-ray structure of SHP2 shows a multidomain architecture compatible with an allosteric regulatory mechanism: under basal conditions SHP2 is inactive, because its N-terminal Src homology 2 (N-SH2) domain blocks the active site of the protein tyrosine phosphatase (PTP) domain. Binding of the N-SH2 domain to a phosphopeptide (PP) ligand causes SHP2 activation by favoring dissociation of the N-SH2 and PTP domains. To characterize this dynamic transition at the atomic level, will be used a combination of state of the art computational methods coupled to X-ray scattering (XS) and biochemical assays. Major goals of the proposed studies are to explain how disease-associated mutations perturb the regulatory events controlling SHP2 function, and design new molecules able to inhibit SHP2 binding to signaling partners. The project implementation is guaranteed by the expertise of the Experienced Researcher (ER) in molecular dynamics (MD) studies of allosteric mechanisms that is complemented by the consolidated expertise of the host institution (HI) in the combined use of MD and XS, together with the external collaboration of an Italian expert in SHP2 biology and a US specialist in XS. Overall, the proposed research will provide a deeper understanding of SHP2 regulation, and dissect the molecular mechanisms implicated in its functional dysregulation in human disease. The planned studies are expected to provide a new class of lead compounds to treat SHP2-associated diseases. Finally, a new computational approach for the design of peptidomimetic inhibitors will be developed.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MARS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MARS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

Drought (2020)

Drought coping strategies in southern Africa 1966-2016

Read More  

INTERGLP1 (2020)

Dissecting GLP-1 receptor internalization pathways using genetic and pharmacological tools

Read More  

POSPORI (2019)

Polymer Optical Sensors for Prolonged Overseeing the Robustness of civil Infrastructures

Read More